Bronchiectasis with or without elevated sweat chloride 1 (BESC1): A Patient Guide

Note: BESC1 is an ultra-rare condition, and evidence is based largely on a small number of reported cases and extrapolation from non-CF bronchiectasis. This guide is an educational resource; never change treatments without consulting your own specialist team.

Bronchiectasis with or without elevated sweat chloride 1 (BESC1) is an ultra-rare genetic condition that affects the body’s ability to balance salt and fluids. For many families, the journey begins with symptoms that look identical to cystic fibrosis, such as very salty skin, a chronic cough, or difficulty gaining weight in infancy ^[1]. However, BESC1 is a distinct “mimic” of cystic fibrosis caused by biallelic pathogenic mutations in the CA12 gene rather than the CFTR gene ^[2]. While the symptoms overlap, the underlying biological cause is different, which means the strategies for managing health must be tailored specifically to this rare diagnosis ^[1].

The CA12 gene is responsible for an enzyme called Carbonic Anhydrase XII, which helps regulate the chemical environment and ion transport in the sweat glands and the lungs ^[3]. When this enzyme is not working correctly, the body “wastes” salt through sweat, leading to a high risk of dehydration and hyponatremia (dangerously low blood sodium) ^[4]. In the lungs, this imbalance disrupts the protective fluid layer of the airways, making them susceptible to chronic inflammation, mucus buildup, and bronchiectasis, a condition where the airways become permanently widened and scarred ^[5]. Because these challenges affect multiple systems, patients with BESC1 require a specialized, multidisciplinary care team—often involving experts in rare disease and non-CF bronchiectasis—to monitor their growth, lung function, and electrolyte levels ^[6].

Living with BESC1 involves a proactive approach to daily care centered on two main pillars: individualized salt replacement and lung protection ^[2]. Because the body cannot hold onto salt effectively, patients must follow a prescribed intake of extra salt and fluids, especially during infancy, illness, or hot weather ^[4]. Simultaneously, a regular, customized routine of airway clearance is essential to keep the lungs clear of mucus and prevent infections ^[7]. It is important to know that while “breakthrough” cystic fibrosis medications called CFTR modulators are highly publicized, they are not indicated or expected to work for BESC1 alone ^[1]. Instead, health is managed through targeted salt supplementation and standard respiratory therapies ^[7][2].

While a diagnosis of such a rare condition can feel overwhelming, it provides the clarity needed to avoid ineffective treatments and focus on the strategies that truly support your health. By working closely with specialists who understand the unique mechanics of the CA12 mutation, you can create a stable daily routine that protects the lungs and keeps the body in balance. With consistent monitoring and a focus on customized salt and fluid management, individuals with BESC1 can find a stable path forward ^[4][2].